Granted Patent
B2
US 7,585,860 · App. 12/027,553 · Granted Sep 8, 2009
Substituted oxazolidinones and their use in the field of blood coagulation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to the field of blood coagulation. Novel oxazolidinone derivatives of the general formula (I) processes for their preparation and their use as medicinally active compounds for the prophylaxis and/or treatment of disorders are described.
Claims (3)
1. A compound of formula:
or a hydrate thereof.
2. The compound of claim 1 , wherein said compound is a hydrate of the compound of formula:
Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 12, 2012
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029277/0713 →
CHANGE OF NAME
Recorded Jul 27, 2011
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 026661/0406 →
CORRECTION IN COVER SHEET PREVIOUSLY RECORDED
Recorded Apr 21, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022575/0337 →
MERGER
Recorded Apr 8, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022520/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 31, 2008
From: STRAUB, ALEXANDER; LAMPE, THOMAS; POHLMANN, JENS; ROEHRIG, SUSANNE; PERZBORN, ELISABETH; SCHLEMMER, KARL-HEINZ; PERNERSTORFER, JOSEPH
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 020729/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 31, 2008
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AKTIENGESELLSCHAFT
Reel/Frame 020729/0125 →